Cardiff University

Parker Aerospace Joins HyFIVE Consortium to Advance Aviation Liquid Hydrogen Fuel System Development

Retrieved on: 
Wednesday, April 24, 2024

Parker Aerospace , a business segment of Parker Hannifin Corporation , the global leader in motion and control technologies, will participate in the HyFIVE consortium of industry and academic partners developing a world-leading liquid hydrogen fuel system and supply chain supporting zero-emission aviation in the 2030s.

Key Points: 
  • Parker Aerospace , a business segment of Parker Hannifin Corporation , the global leader in motion and control technologies, will participate in the HyFIVE consortium of industry and academic partners developing a world-leading liquid hydrogen fuel system and supply chain supporting zero-emission aviation in the 2030s.
  • In addition to Parker Aerospace, HyFIVE includes fellow industry partners Marshall and GKN Aerospace, as well as academic partners University of Manchester, University of Bath and Cardiff University.
  • The objective of the HyFIVE consortium is to develop, test and validate a modular and scalable cryogenic hydrogen fuel system architecture appropriate for multiple types of aircraft, and support of hydrogen electric propulsion or hydrogen combustion powertrains.
  • The initiative will address technology development for hydrogen fuel systems in five key areas: storage, conveyance, indication, fueling and venting.

Metabolon and Cardiff University Centre for Neuropsychiatric Genetics and Genomics Forge Alliance to Propel Multiple Sclerosis Research

Retrieved on: 
Tuesday, March 12, 2024

MORRISVILLE, N.C., March 12, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a partnership with Cardiff University Centre for Neuropsychiatric Genetics and Genomics, a renowned institution at the forefront of biomedical research. This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).

Key Points: 
  • This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).
  • MS is a neuroinflammatory disorder that affects the central nervous system, giving rise to a range of physical and neuropsychological challenges.
  • For years, the Cardiff University Centre for Neuropsychiatric Genetics and Genomics has been following MS patients and developing cutting-edge tools for clinicians and researchers.
  • To learn more about Metabolon's research and development efforts in neurodegeneration diseases, including Alzheimer's, Parkinson's, and MS, visit https://www.metabolon.com/applications/neuroscience/

Metabolon and Cardiff University Centre for Neuropsychiatric Genetics and Genomics Forge Alliance to Propel Multiple Sclerosis Research

Retrieved on: 
Tuesday, March 12, 2024

MORRISVILLE, N.C., March 12, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced a partnership with Cardiff University Centre for Neuropsychiatric Genetics and Genomics, a renowned institution at the forefront of biomedical research. This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).

Key Points: 
  • This collaboration is poised to discover new biomarkers to accelerate advancements in the understanding and treatment of multiple sclerosis (MS).
  • MS is a neuroinflammatory disorder that affects the central nervous system, giving rise to a range of physical and neuropsychological challenges.
  • For years, the Cardiff University Centre for Neuropsychiatric Genetics and Genomics has been following MS patients and developing cutting-edge tools for clinicians and researchers.
  • To learn more about Metabolon's research and development efforts in neurodegeneration diseases, including Alzheimer's, Parkinson's, and MS, visit https://www.metabolon.com/applications/neuroscience/

Endangered by the 49th Parallel: How political boundaries inhibit effective conservation

Retrieved on: 
Wednesday, February 7, 2024

Some Canadian scientists advocate for conservation efforts to focus on species unique to this country, while others argue for a more global focus.

Key Points: 
  • Some Canadian scientists advocate for conservation efforts to focus on species unique to this country, while others argue for a more global focus.
  • However, most ignore the fact that the U.S. – Canada border creates endangered species.
  • We must consider the global context when designing Canadian endangered species, and biodiversity, protections.

Time for a chat about Chats

  • Take the Yellow-breasted Chat, a charismatic warbler listed as Endangered under the (Canadian) federal Species at Risk Act (SARA).
  • The Canadian fragment of the Southern Mountain subspecies survives in a handful of sites in B.C.
  • According to the International Union for Conservation (IUCN) Red List, though, the global population is around 17 million across North America.


The federal Committee on the Status of Endangered Wildlife in Canada (COSEWIC) says the Southern Mountain subspecies “occurs at the northern edge of its range in Canada” as a peripheral to the huge American core population. In other words, the Yellow-breasted Chat is listed as endangered in Canada because, in 1846, the British accepted that the border with the U.S. should lie at the 49th parallel.

Endangered, or not?

  • The question then is, should conservation efforts be dedicated to tiny Canadian populations of otherwise healthy species?
  • Elder Richard Armstrong’s traditional story illuminates why the Chat, which his people call xʷaʔɬqʷiləm’ (whaa-th-quil lem), matters to the transboundary Nsyilxcən speaking Peoples.
  • The First Nation’s special care for the Chat, in turn, makes it more likely that COSEWIC’s listing will help.
  • Fourteen of those were, like the chat, ‘Least Concern’ globally, while just one bat species, Myotis lucifugus, was universally assessed as endangered.
  • Another study scored 729 COSEWIC-listed species, subspecies and populations to assess the global context of these conservation measures.

Overcoming jurisdictional rarity

  • I live in one of the skinny fragments of shrub steppe that snake up from the Columbia plateau in the U.S. through Osoyoos to Kamloops — an area which seems purpose-built for jurisdictional rarity.
  • Take the burrowing owl, a ground-nesting raptor with a vexed facial expression.
  • Meanwhile, the IUCN’s range map for the burrowing owl (Least Concern), stretches from Alberta to Argentina.
  • Public information about endangered species dodges jurisdictional rarity, leaving decisions to scientists and bureaucrats.

Reframing the conversation

  • Scientists may feel protective towards Canadian populations they know and love, but citizens won’t want limited resources wasted on conservation of un-endangered species.
  • Scientific and political processes gummed up with peripheral species make it less likely that critically imperilled species will be saved.
  • Where good reasons exist to protect peripheral species, those arguments should be public and open to debate.
  • is considering, should require that peripheral species be identified transparently, using agreed definitions, as ‘endangered in B.C.’, or ‘threatened in Canada’.


Greg Garrard's research is funded by the Social Sciences and Humanities Research Council of Canada, grant no. 435-2020-1220. Sarah Raymond's research visit to UBC Okanagan was funded by UKRI-MITACS Globalink.

Rwanda deal: why the media should focus more on the policy and less on the politics of immigration

Retrieved on: 
Wednesday, February 7, 2024

Much of the coverage has been about the plan to send those who enter the UK without legal paperwork to Rwanda.

Key Points: 
  • Much of the coverage has been about the plan to send those who enter the UK without legal paperwork to Rwanda.
  • We argue that the media ought to take note of this issue as it continues to cover the government’s Rwanda policy.
  • To fulfil their obligations as public service broadcasters, the UK’s TV media outlets in particular should focus more on the policy, not the politics.

Party politics over scrutiny

  • The vast majority – 72% of stories – discussed the bill in relation to Westminster party politics.
  • Specifically, how it would affect politicians’ reputations and prospects in the next election.
  • But while most of the news items we examined referenced these obligations, they did not include a robust scrutiny of the legislation.
  • What he’s got is a battle in his own party too.”

Personality over policy

  • These were largely to do with humanitarian concerns about treatment of child migrants and modern slavery victims.
  • Broadcasters focused on how the Conservatives were determined to vote against these recommendations to “send a message” to the Lords.
  • Groups like the UN Refugee Agency or the Refugee Council accounted for only 9% of the total sources in our sample.

What is the media’s responsibility?

  • Our analysis suggests that broadcasters used this same logic when reporting on regular government activity outside of an election cycle.
  • UK public service broadcasters have a responsibility to provide the public with accurate, impartial and informative reporting.


The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.

Lara Announces Board and Management Changes

Retrieved on: 
Monday, January 8, 2024

Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Lara Exploration Ltd. (TSXV: LRA) ("Lara") is pleased to announce the appointment of Simon Ingram as President, CEO, and a Director of the Company, with Miles Thompson remaining in his role as Chairman.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Lara Exploration Ltd. (TSXV: LRA) ("Lara") is pleased to announce the appointment of Simon Ingram as President, CEO, and a Director of the Company, with Miles Thompson remaining in his role as Chairman.
  • Miles Thompson commented: "On behalf of us all at Lara, I'd like to welcome Simon to the team, we very much look forward to working with him again.
  • The Planalto Copper-Gold discovery in the Carajás of Brazil is now back 100%-owned, and we see a great opportunity to create value for shareholders by moving it through the next development stages."
  • Simon Ingram is a senior international executive with strong technical and public company leadership experience, which he gained during over 25 years working globally in natural resource industries.

Hemab Therapeutics Appoints Dr. Akshay Vaishnaw to Board of Directors and Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, January 4, 2024

The company also announced CEO Benny Sorensen, MD, PhD, will present an update on Hemab's progress and outlook for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, at 4:30 PM PST/7:30 PM EST.

Key Points: 
  • The company also announced CEO Benny Sorensen, MD, PhD, will present an update on Hemab's progress and outlook for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, at 4:30 PM PST/7:30 PM EST.
  • We welcome Akshay and the expertise he brings to Hemab and its mission."
  • "Akshay joins our Board at a time when his experience leading translational research, clinical development and delivering regulatory success will be invaluable," said Dr. Sorensen.
  • "I am thrilled to have his partnership and to bring his passion for science and commitment to building people-focused cultures to Hemab."

Novel Genetic Priority Score Unveiled to Enhance Target Prioritization in Drug Development

Retrieved on: 
Wednesday, January 3, 2024

NEW YORK, Jan. 3, 2024 /PRNewswire-PRWeb/ -- Driven by the need for a better way to prioritize targets for drug development, the Icahn School of Medicine at Mount Sinai has led the development of a novel "genetic priority score" (GPS) that will integrate various types of human genetic data into a single easy-to-interpret score.

Key Points: 
  • The score measures the general ability of a gene to be targeted by drugs; genes with a high score in the new tool are more likely to succeed as a drug target.
  • The score identifies both known drug gene targets as well as potential novel therapeutic targets.
  • The GPS, with its potential to streamline target prioritization, is positioned to have a significant impact on drug development.
  • The paper is titled "Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications."

Unlocking the Human Genome: Innovative Machine Learning Tool Predicts Functional Consequences of Genetic Variants

Retrieved on: 
Thursday, December 14, 2023

NEW YORK, Dec. 14, 2023 /PRNewswire-PRWeb/ -- In a novel study, researchers from the Icahn School of Medicine at Mount Sinai introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain- and loss-of-function variants across the genome.

Key Points: 
  • NEW YORK, Dec. 14, 2023 /PRNewswire-PRWeb/ -- In a novel study, researchers from the Icahn School of Medicine at Mount Sinai introduced LoGoFunc, an advanced computational tool that predicts pathogenic gain- and loss-of-function variants across the genome.
  • LoGoFunc uses machine learning trained on a database of known pathogenic gain-of-function and loss-of-function mutations identified in the literature.
  • "Beyond personalized medicine, LoGoFunc has implications for drug discovery, genetic counseling, and accelerating genetic research.
  • "We believe that LoGoFunc will be a powerful tool for deciphering the functional consequences of genetic variations.

Trading Technologies taps three experienced capital markets business leaders for new senior management roles, effective Jan. 1

Retrieved on: 
Monday, December 4, 2023

CHICAGO, Dec. 4, 2023  /PRNewswire/ -- Trading Technologies International, Inc. (TT), a global capital markets technology platform provider, announced today that the firm has appointed three industry leaders – each with decades of relevant experience – to key new posts on its leadership team. Joining on Jan. 1, 2024 will be Justin Llewellyn-Jones as Chief Operating Officer (COO), Christopher Heffernan as EVP Fixed Income and Alun Green as EVP Futures & Options.

Key Points: 
  • As COO, Llewellyn-Jones will lead all of the firm's market-facing business to drive its multi-asset growth, in collaboration with the heads of each business line.
  • Heffernan will focus on building TT's global fixed income business, while Green will focus on expanding the company's core futures and options franchise.
  • Heffernan has over two decades of fixed income experience in sales and trading, business development, and leadership roles.
  • Over the last decade, he helped build two fixed income trading businesses, with focuses on electronic and algorithmic trading, exchange-traded funds (ETFs) and portfolio trading.